
|Articles|October 1, 2012
SCC prevention is real target in treating actinic keratoses
Options for topical treatment of actinic keratoses (AKs) are increasing, but in choosing a management approach, dermatologists should keep in mind that AKs are a premalignant condition, and the ultimate goal of therapy is prevention of squamous cell carcinoma (SCC). Field treatment is the key to managing the entire disease, says Neal Bhatia, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
KT-621 Produces 98% STAT6 Degradation in AD Patients
2
Transparency Gaps in Prior Authorization Denials and Their Impact on Dermatologic Care
3
AI at the Bedside: How Automated Solutions are Transforming Vitiligo Management
4
Celebrating a Year of Growth and Research
5



















